The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact

​ID Corner: A Case of Varicella Zoster Virus Reactivation Post COVID-19 Immunization

by Aaron Klysen, BSPS, 2022 PharmD Candidate, Kasey Arnhoelter, PharmD, BCPS

"Recent efforts to slow the COVID-19 pandemic have focused largely on immunization. With COVID-19 vaccines being readily available, approximately 55% of the United States population is now fully vaccinated, with many citizens having received one of the two available mRNA products. Both mRNA vaccines, produced by Pfizer and Moderna, have proven to be safe and effective in clinical trials.1,2 Since their introduction to the public, under Food and Drug Administration Emergency Use Authorization, the Vaccine Adverse Events Reporting System (VAERS) has continued to collect data on adverse events surrounding COVID-19 vaccination. Furthermore, anecdotal case reports have been published throughout the vaccination period on potential, but rare, adverse effects. Below, we present a case of herpes zoster status –post-COVID-19 vaccination with Pfizer’s BNT162b2 vaccine."

Keywords:  COVID-19 Vaccines, Tacrolimus, Valacyclovir, Prednisone, COVID-19, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Kidney Transplantation, Diabetes Mellitus, Type 2, Cephalexin, Vaccines, Immunosuppression, Pain, Fatigue, Physical Examination, Hospitals, Herpes Zoster, Patient Reported Outcome Measures

​Download PDF 

2021 November/December Table of Contents ​

The Journal of the Pharmacy Society of Wisconsin


Past Issues

2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

thejournal@pswi.org
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact